SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001367644-09-000009
Filing Date
2009-03-06
Accepted
2009-03-05 19:39:21
Documents
12
Period of Report
2008-12-31

Document Format Files

Seq Description Document Type Size
1 final10kvs1.htm 10-K 1902694
2 GRAPHIC ballot.jpg GRAPHIC 751
3 GRAPHIC ballotx.jpg GRAPHIC 762
4 exhibit21_1.htm EX-21 11311
5 ex23.htm EX-23 3498
6 exhibit10_21.htm EX-10 154646
7 exhibit10_25.htm EX-10 66465
8 exhibit10_27.htm EX-10 75334
9 exhibit31_1.htm EX-31 14229
10 exhibit31_2.htm EX-31 14084
11 exhibit32_1.htm EX-32 4588
12 exhibit32_2.htm EX-32 4700
  Complete submission text file 0001367644-09-000009.txt   2255317
Mailing Address 2273 RESEARCH BLVD, SUITE 400 ROCKVILLE MD 20850
Business Address 2273 RESEARCH BLVD, SUITE 400 ROCKVILLE MD 20850 (301) 795-1800
Emergent BioSolutions Inc. (Filer) CIK: 0001367644 (see all company filings)

IRS No.: 141902018 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-33137 | Film No.: 09660236
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences